Avaliação do suporte social e da adesão medicamentosa em pacientes com doença arterial coronariana

Autores

  • Bruno Rodrigues Hermano Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brasil, brunorhermano@gmail.com.
  • Alba Lúcia Bottura Leite de Barros Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brasil, barros.alba@unifesp.br. https://orcid.org/0000-0003-2691-3492
  • Juliana de Lima Lopes Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brasil, juliana.lima@unifesp.br. https://orcid.org/0000-0001-6915-6781
  • Mariana Alvina dos Santos Universidade Federal do Mato Grosso do Sul (UFMS), Três Lagoas, Mato Grosso do Sul, Brasil, marifamema@yahoo.com.br. https://orcid.org/0000-0002-7940-6673
  • Camila Takao Lopes Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brasil, ctlopes@unifesp.br. https://orcid.org/0000-0002-6243-6497
  • Vinicius Batista Santos Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brasil, v.santos@unifesp.br. https://orcid.org/0000-0001-5130-5523

DOI:

https://doi.org/10.5216/ree.v23.66979

Palavras-chave:

Apoio Social, Adesão à Medicação, Doença da Artéria Coronariana, Enfermagem

Resumo

Objetivo: Avaliar a adesão medicamentosa e o suporte social percebido e sua associação em pacientes hospitalizados por Doença Arterial Coronária. Método: Estudo transversal envolvendo pacientes hospitalizados por Síndrome Coronariana Aguda ou Crônica. A adesão medicamentosa foi avaliada pelo Brief Medication Questionnaire e o suporte social pela Escala de Apoio Social do Medical Outcomes Study. Valor p<0,05 foi considerado como significativo. Resultados: Incluídos 59 pacientes, sendo que 50,8% foram classificados como potencial para não adesão e 37,3% como não aderentes. O suporte social percebido identificado foi considerado como quase sempre a sempre. Os pacientes aderentes e aqueles classificados como potencial para não adesão apresentaram maior escore no domínio emocional/informacional quando comparados com aqueles classificados como potencial para adesão (p=0,01). Conclusão: Houve alta prevalência de baixa adesão medicamentosa e altos escores de suporte social percebido. O suporte emocional e de informação apresentou associação com os níveis de adesão medicamentosa.

Downloads

Não há dados estatísticos.

Referências

Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST- segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2021;42(14):1289- 1367. https://doi.org/10.1093/eurheartj/ehaa575.

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. https://doi.org/10.1093/eurheartj/ehx393.

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal. 2020;41(3):407–77. https://doi.org/10.1093/eurheartj/ehz425.

Brasil. Ministério da Saúde (BR). Sistema de Informações Hospitalares do SUS (SIH/SUS) [Internet]. Brasília, DF; 2019 [acesso em: 05 jun. 2021]. Disponível em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/niuf.def.

Piepoli MF, Corrà U, Dendale P, Frederix I, Prescott E, Schmid JP, et al. Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur J Prev Cardiol. 2016;23(18):1994–2006. https://doi.org/10.1177/2047487316663873.

De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323. https://doi.org/10.1016/S1474-5151(03)00091-4.

Kipralani S, Goggins K, Nwosu S, Schildcrout J, Mixon AS, McNaughton C, et al. Medication Nonadherence Before Hospitalization for Acute Cardiac Events. J Heal Commun. 2016;20(2):34–42. https://doi.org/10.1080/10810730.2015.1080331.

Griep RH, Chor D, Faerstein E, Werneck GL, Lopes CS. Construct validity of the Medical Outcomes Study’s social support scale adapted to Portuguese in the Pró- Saúde Study. Cad. Saúde Pública. 2005;21(3):703–14. https://doi.org/10.1590/S0102-311X2005000300004.

Magrin ME, Addario MD, Greco A, Miglioretti M, Sarini M, Scrignaro M, et al. Social Support and Adherence to Treatment in Hypertensive Patients: a meta-analysis. Ann Behav Med. 2015; 49(3):07–18 https://doi.org/10.1007/s12160-014-9663-2.

Mondesir FL, Carson AP, Durant RW, Lewis MW, Safford MM, Levitan EB. Association of functional and structural social support with medication adherence among individuals treated for coronary heart disease risk factors: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. PLoS ONE. 2018;13(6): e0198578. https://doi.org/10.1371/journal.pone.0198578.

Nouamou I, El Mourid M, Ragbaoui Y, Habbal R. Medication adherence among elderly patients with coronary artery disease: our experience in Morocco. Pan Afr Med J. 2019; 32(8):1–8. https://doi.org/10.11604/pamj.2019.32.8.12415.

Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–24. https://doi.org/10.1016/s0738-3991(98)00107-4.

Bem AJ, Neumann CR, MengueSS. Teste de Morisky Green e Brief Medication Questionnaire para avaliar adesão a medicamentos. Rev Saúde Pública. 2012;46(2):279–89. https://doi.org/10.1590/S0034-89102012005000013.

Zanini DS, Peixoto EM. Social support scale (MOS-SSS): Analysis of the psychometric properties via item response theory. Paidéia (Ribeirão Preto). 2016;26(65):359–68. https://doi.org/10.1590/1982-43272665201612.

Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;21(8):e016982. https://doi.org/10.1136/bmjopen-2017-016982.

Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health. 2019;41(1):e84–e94. https://doi.org/10.1093/pubmed/fdy088.

Santos VB, Silva LL, Guizilini S, Valente IB, Barbosa CB, Carneiro TAB, et al. Adherence to antiplatelet and statin therapy by patients with Acute Coronary Syndrome following discharge. Enferm Clin. 2020;S1130-8621(20)30237-0. https://doi.org/10.1016/j.enfcli.2020.02.020.

Oscalices MIL, Okuno MFP, Lopes MCBT, Batista REA, Campanharo CRV. Health literacy and adherence to treatment of patients with heart failure. Rev Esc Enferm USP. 2019;53:e03447. http://dx.doi.org/10.1590/S1980-220X201703980344.

Mantovani MF, Mattei ÂT, Arthur JP, Ulbrich EM, Moreira RM. The use of the Brief Medication Questionnaire in medication accession of Hypertensives J Nurs UFPE On Line. 2015;9(1):84–90. https://doi.org/10.5205/reuol.6817-60679-1-ED.0901201512.

Bernal DDL, Bereznicki LRE, Chalmers L, Castelino RL, Thompson A, Davidson PM, Peterson GM. Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All? American Journal of Cardiovascular Drugs. 2015;16(1):9–17. https://doi.org/10.1007/s40256-015-0149-9.

Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017;99:269–76. https:// doi.org/10.1016/j.ypmed.2017.03.008.

Pushkarev G, Kuznetsov V, Yaroslavskaya E, Bessonov I. Social support for patients with coronary artery disease after percutaneous coronary intervention. Journal of Psychosomatic Research. 2019;119:74–8. https://doi.org/10.1016/j.jpsychores.2019.02.011.

Enriquez M, Mercier DA, Cheng AL, Banderas JW. Perceived Social Support Among Adults Struggling With Adherence to HIV Care and Treatment. Journal of the Association of Nurses in AIDS Care. 2019;30(3):362– 71. https://doi.org/10.1097/jnc.0000000000000059.

Uchmanowicz B, Chudiak A, Uchmanowicz I, Rosińczuk J, Froelicher ES. Factors influencing adherence to treatment in older adults with hypertension. Clin Interv Aging. 2018;13:2425–41. https://doi.org/10.2147/CIA.S182881.

Adisa R, Olajide OO, Fakeye TO. Social Support, Treatment Adherence and Outcome among Hypertensive and Type 2 Diabetes Patients in Ambulatory Care Settings in Southwestern Nigeria. Ghana Med J. 2017;51(2):64–77. http://dx.doi.org/10.4314/gmj.v51i2.4.

Palacio AM, Vidot DC, Tamariz LJ, Uribe C, Hazel- Fernandez L, Li H, et al. Can We Identify Minority Patients at Risk of Nonadherence to Antiplatelet Medication at the Time of Coronary Stent Placement? J Cardiovasc Nurs. 2017;32(6):522–29. https://doi.org/10.1097/jcn.0000000000000387.

Albuquerque NLS, Oliveira ASS, Silva JM, Araújo TL. Association between follow-up in health services and antihypertensive medication adherence. Rev Bras Enferm. 2018;71(6):3006–12. http://dx.doi.org/10.1590/0034-7167-2018-0087.

Downloads

Publicado

13/07/2021

Edição

v. 23 (2021)

Seção

Artigo Original

Licença

Copyright (c) 2021 Revista Eletrônica de Enfermagem

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.